Skip to main content

Diagnostic options · UAE

Genetic Disease tests in Dubai & UAE

Compare available Genetic Disease tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

23

Listed price range

2,800.00–4,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic Disease test prices

Showing 16–23 of 23 matching tests.

Genetic Disease diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-3641
NPHS1 Gene Nephrosis, Finnish Type Genetic Test

This genetic test identifies pathogenic mutations in the NPHS1 gene, which are responsible for congenital nephrotic syndrome of the Finnish type.

Peripheral Whole Blood (DNA Extraction) 3 to 4 Weeks (21–28 Days) 2,800.00 AED
View
View test specifications and preparation
What it measures
["NPHS1 gene mutations", "Pathogenic variants (SNVs, Indels, CNVs, Splice-Altering Variants)"]
Parameters
[]
Preparation
[]
Indications
["Congenital nephrotic syndrome", "Unexplained proteinuria in infancy", "Positive family history of autosomal recessive nephropathy", "Siblings of affected probands", "Pre-conception carrier screening in high-risk families"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 95208-4 ICD-10: N04.9, Z15.89
Clinical summary
This genetic test identifies pathogenic mutations in the NPHS1 gene, which are responsible for congenital nephrotic syndrome of the Finnish type.
TEST-5592
SLC17A5 Gene Analysis (Sialuria Finnish Type) Test

This test evaluates the SLC17A5 gene for pathogenic variants associated with free sialic acid storage disorders, including Salla disease.

Whole Blood (EDTA) or Finger‑Prick FTA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SLC17A5 gene", "Copy Number Variations (CNVs) within the SLC17A5 gene"]
Parameters
[]
Preparation
["Do not discontinue prescribed medication without consulting your physician", "A pre-test consultation with a medical geneticist is recommended"]
Indications
["Diagnostic confirmation of suspected Salla disease", "Carrier screening for individuals with a family history", "Family planning for couples at risk"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: E77.8
Clinical summary
This test evaluates the SLC17A5 gene for pathogenic variants associated with free sialic acid storage disorders, including Salla disease.
TEST-3372
SPATA16 Gene (SPGF6) Genetic Test

This test identifies pathogenic mutations in the SPATA16 gene associated with spermatogenic failure type 6 (SPGF6), a cause of male infertility.

Peripheral whole blood (EDTA) 21–28 business days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic mutations in the SPATA16 gene", "Spermatogenic failure type 6 (SPGF6)"]
Parameters
[]
Preparation
["Mandatory pre-test genetic counseling session", "Provide peripheral blood sample via standard venipuncture"]
Indications
["Diagnosis of spermatogenic failure type 6 (SPGF6)", "Evaluation of male infertility", "Guidance for assisted reproductive technologies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: N46.0, N46.1
Clinical summary
This test identifies pathogenic mutations in the SPATA16 gene associated with spermatogenic failure type 6 (SPGF6), a cause of male infertility.
TEST-4673
SQSTM1 Gene Paget Disease of Bone Genetic Test

This test evaluates the SQSTM1 gene for pathogenic variants associated with Paget disease of bone and related disorders.

Peripheral whole blood 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["SQSTM1 gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"]
Parameters
[]
Preparation
[]
Indications
["Adults with early-onset bone deformities", "Adults with unexplained fractures", "Adults with a family history of Paget disease"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92878-1 ICD-10: M88.9
Clinical summary
This test evaluates the SQSTM1 gene for pathogenic variants associated with Paget disease of bone and related disorders.
TEST-5421
TYRP1 Gene Albinism, Oculocutaneous Type 3 (OCA3) Genetic Test

This test identifies pathogenic variants in the TYRP1 gene associated with oculocutaneous albinism type 3 (OCA3). It utilizes next-generation sequencing (NGS) for comprehensive ana...

Peripheral Whole Blood (EDTA) or Buccal Swab 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["TYRP1 gene sequence", "Copy number variants in TYRP1"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any bleeding disorders"]
Indications
["Suspected diagnosis of oculocutaneous albinism type 3 (OCA3)", "Family cascade testing for OCA3", "Reproductive planning for families with OCA3"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94853-9 ICD-10: E70.330
Clinical summary
This test identifies pathogenic variants in the TYRP1 gene associated with oculocutaneous albinism type 3 (OCA3). It utilizes next-generation sequencing (NGS) for comprehensive analysis.
TEST-3514
WDR19 Gene Senior‑Loken Syndrome Type 8 Genetic Test

This test analyzes the WDR19 gene for mutations associated with Senior-Loken syndrome type 8.

Peripheral Whole Blood or Extracted DNA 10–14 Business Days 2,800.00 AED
View
View test specifications and preparation
What it measures
["WDR19 gene coding region variants (SNVs, indels)"]
Parameters
[]
Preparation
[]
Indications
["Suspected Senior-Loken syndrome type 8", "Family history of Senior-Loken syndrome type 8", "Clinical presentation consistent with ciliopathy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94252-3 ICD-10: Q87.89, Q61.4
Clinical summary
This test analyzes the WDR19 gene for mutations associated with Senior-Loken syndrome type 8.
TEST-2583
WDR62 Gene Microcephaly with Cortical Malformations, Autosomal Recessive Type 2 Genetic Test

This test identifies pathogenic variants within the WDR62 gene associated with autosomal recessive primary microcephaly type 2 and cortical malformations.

Whole Blood, Extracted DNA, Dried Blood Spot (FTA Card) 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the WDR62 gene", "Single nucleotide variants", "Small indels"]
Parameters
[{"name": "Diagnostic Sensitivity", "reference_range": ">99.9% for single nucleotide variants and small indels within WDR62"}]
Preparation
["Do not discontinue prescribed medications without consulting your treating physician.", "Inform phlebotomist of all current medications and supplements."]
Indications
["Newborns and infants presenting with severe congenital microcephaly (head circumference < -3 SD)", "Cortical malformations on neuroimaging", "Family history suggesting recessive inheritance"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 86709-3 ICD-10: Q02, Q04.8
Clinical summary
This test identifies pathogenic variants within the WDR62 gene associated with autosomal recessive primary microcephaly type 2 and cortical malformations.
TEST-5439
WDR72 Gene Amelogenesis Imperfecta Type IIA3 (AI2A3) Genetic Test

This genetic test identifies pathogenic variants in the WDR72 gene associated with Amelogenesis Imperfecta Type IIA3.

Whole blood (EDTA) or FTA card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic single nucleotide variants in WDR72 gene", "Small insertion/deletions in WDR72 gene"]
Parameters
[]
Preparation
["Complete pre-genetic counselling session", "Provide a three-generation pedigree chart"]
Indications
["Individuals with hypoplastic enamel", "Individuals with unusual tooth discoloration", "Individuals with a family history of hereditary dental anomalies and associated dermatological/skeletal signs"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: K00.5
Clinical summary
This genetic test identifies pathogenic variants in the WDR72 gene associated with Amelogenesis Imperfecta Type IIA3.

Category overview

Genetic Disease: overview

Confronting the possibility of a hereditary illness requires highly precise diagnostics to unlock the right specialized care for you or your family. Within our elite Genetics services, testing for Genetic Disease focuses on identifying the specific DNA mutations responsible for inherited monogenic, metabolic, or syndromic disorders. Utilizing cutting-edge diagnostic technology, this vital molecular screening establishes a definitive diagnosis, providing the critical data necessary to safely guide life-changing medical management and specialized therapeutic care. Trusted for sensitive genetic diagnostics across the top diagnostic labs in the UAE, DNA Labs guarantees absolute patient confidentiality, unparalleled diagnostic accuracy, and highly efficient turnaround times. Secure the critical diagnostic insights your family deserves—schedule your genetic disease testing in UAE, coordinate a secure sample collection, or reach out to our dedicated medical genetics experts.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.